| NEI Psychopharmacology Congress |
|
|
|
ADHD in the Context of Comorbidities
Andrew J Cutler, MD
Attention deficit-hyperactivity disorder (ADHD) often presents with comorbid conditions, including depression, anxiety, and substance use disorders. In this case-based presentation, Dr. Andrew Cutler walks the audience through several different patient case files from his own practice in order to explore the diagnosis and treatment options for patients presenting with ADHD and comorbid mental health conditions.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
When Patients Present With Agitation and Aggression: Management Considerations
Rona J Hu, MD
Agitation is a serious and potentially dangerous consequence of many psychiatric conditions. In this presentation, Dr. Rona Hu explores the neurobiology of aggressive behaviors and discusses pharmacological and non-pharmacological strategies for ameliorating agitation and preventing the escalation to violence in patients with mental illness.
CME credit: 0.50
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
It’s a Dirty Drug, But Somebody’s Got To Prescribe It
Rona J Hu, MD
In this presentation, Dr. Rona Hu describes optimal dosing and monitoring strategies for lithium, lamotrigine, clozapine, and the tricyclic antidepressants.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Keeping up With the Clinical Advances: ADHD
Andrew J Cutler, MD
In this presentation, Dr. Andrew Cutler will discuss various treatment options available for ADHD including several new medication formulations, and how to customize treatment selection to the individual needs of each patient, which will likely increase treatment adherence and improve quality of life for patients with ADHD.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
The Cognitive Burden of Mood Disorders
Roger S McIntyre, MD, FRCPC
Recently published study point to a key role of cognition in mediating functional recovery in major depressive disorder. Here, Dr. Roger McIntyre reviews the theory of cognition as well as the evidence for a key role of cognition in major depressive disorder. Assessment of cognition in depression and potential treatment strategies are also discussed.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Recognizing and Treating Patients With Mixed and Bipolar Depression
Thomas L Schwartz, MD
Mixed features are present in as many as 70% of patients during a major depressive episode; unfortunately, failure to recognize mixed features in the context of depression all too commonly leads to treatment strategies that are inappropriate and possibly counterproductive. Here, Dr. Thomas Schwartz will discuss strategies for identifying mixed features in patients with depression as well as novel treatment guidelines for optimizing outcomes in patients with depressive episodes that are part of a bipolar rather than unipolar illness.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Planet of the Apps: Leveraging Technology
Leslie Citrome, MD, MPH
The digital age has the potential for streamlining research on mental health issues as well as aiding in the optimization of patient care. Here, Dr. Leslie Citrome discusses strategies for utilizing modern technology to aid in the treatment of patients with mental health issues.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
How to Use Pharmacogenomic Testing to Predict and Reduce Side Effects of Psychotropic Medications
Rajnish Mago, MD
Our knowledge of the genetic contributions to numerous diseases is increasing exponentially; it is likely that in the near future virtually all health care will be personalized at the level of the genome. In this presentation, Dr. Rajnish Mago provides an update on the benefits and limitations of personalized medicine in managing side effects of psychotropic medications.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Avoiding Nursing Home Placement: Treatment of Secondary Behavioral Symptoms of Dementia
Stephen M Stahl, MD, PhD
Secondary behavioral symptoms of dementia, including aggression, psychosis, depression, and apathy, are often most disturbing to both patients and caregivers and may be the leading drivers of nursing home placement in individuals with dementia. Here, Dr. Stephen Stahl explores some of the pharmacological and non-pharmacological treatments currently available and in testing to alleviate these secondary behavioral symptoms of dementia and possibly delay institutionalization.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Assessment, Prevention, and Treatment of the Neuropsychiatric Consequences of Traumatic Brain Injuries
William M Sauvé, MD
Even a mild traumatic brain injury (mTBI) can put an individual at risk for developing a psychiatric disorder. In this presentation, Dr. William Sauvé presents the latest findings on the causes and consequences of mTBI as well as existing and novel agents that may be used to treat this patient population.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Modifiable Risk Factors and Early Detection: The Sight, Smell, Sound, Taste, and Touch of Dementia
Stephen M Stahl, MD, PhD
With no effective treatment for Alzheimer's disease yet available, efforts have focused on potentially modifiable risk factors that may alter the course of dementia as well as techniques to detect dementia at the earliest point in its progression. In this presentation, Dr. Stephen Stahl provides an update on lifestyle factors (including diet and exercise) that may be manipulated to decrease one's risk of dementia as well as novel methods being explored to detect Alzheimer's disease pathology even before behavioral deficits are evident.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Optimizing Functional Outcomes in Schizophrenia: Managing Negative Symptoms, Cognitive Impairment, and Adverse Effects
Jonathan M Meyer, MD
While the majority of treatment options have focused on treating positive symptoms in schizophrenia, in order to strive for optimal functional outcomes, negative symptoms, and related cognitive deficits must be addressed. In this presentation, Dr. Jonathan Meyer presents current findings on evidence-based effective treatment strategies to manage negative and cognitive symptoms, adverse side effects, and the importance of monitoring plasma levels for optimal treatment results.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Keeping up With the Clinical Advances: Depression
Stephen M Stahl, MD, PhD
Our understanding of the neurobiology of depression has increased in recent years, there is recognition that the neurobiological substrates of depression may go beyond monoaminergic circuits. In this presentation, Dr. Stephen Stahl provides an update on novel antidepressant treatments that are recently available or in development, including the mechanisms of action that are thought to underlie their potential antidepressant effects.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Medical Comorbidity in Mood Disorders: The Link With Metabolic-Inflammatory Systems
Roger S McIntyre, MD, FRCPC
There is growing evidence that inflammation and metabolic factors such as adiposity may play important roles in the pathophysiology of mental illnesses. Psychiatric and the medical disorders should be considered when selecting treatment, so that treatment not only can avoid harm but can also potentially be selected to suit the specific comorbid population. In this presentation, Dr. Roger McIntyre will discuss how to select treatment strategies that take medical factors into consideration.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Keeping up With the Clinical Advances: Schizophrenia
Jonathan M Meyer, MD
Schizophrenia is a debilitating disease, and is often difficult to treat. Some of the most common obstacles to treatment are issues with adherence, effectiveness, and unwanted side effects. In this presentation, Dr. Jonathan Meyer discusses novel agents in development or recently FDA approved that may aid in many of these challenges.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Moving Toward the Future: New Developments in the Management of Tardive Dyskinesia
Laxman B Bahroo, DO
Tardive dyskinesia (TD) is an ongoing concern for patients treated with antipsychotics. Discontinuation of antipsychotic treatment may offer the best chance of TD remission; however, alternative strategies of TD management must be employed in patients who require continued antipsychotic therapy. In this presentation, Dr. Laxman Bahroo discusses new strategies for treating and managing tardive dyskinesia.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Mood Disorders During Pregnancy and the Postpartum
Marlene P Freeman, MD
The accurate diagnosis and timely treatment of peripartum mood disorders is essential, yet requires consideration of both the mother's and the offspring's health. In this presentation, Dr. Marlene Freeman describes the potential risks associated with peripartum mental illness as well as the evidence base for the risks vs. benefits of treatment options.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|